Abstract
Abstract. In the H‐2‐compatible donor‐recipient combination (BALB/c ± DBA/2), pretransplant donor‐specific blood transfusion (DST) via the portal venous (PV) route significantly prolonged cardiac graft survival. DST via the intravenous (IV) route (systemic circulation) also showed a marked prolongation of heart tissue transplant survival in this model. In the H‐2‐incompatible combination (BALB/c → CBA/H), DST via the IV ‐ but not via the PV ‐ route resulted in accelerated graft rejection.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 199-202 |
| Number of pages | 4 |
| Journal | Transplant International |
| Volume | 2 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1989 |
| Externally published | Yes |
Keywords
- Transfusion effect
- experimental
- experimental ‐ Portal venous route
- heart ‐ Heart transplantation
- intraportal route ‐ Transfusion effect
- transfusion effect
Fingerprint
Dive into the research topics of 'Donor‐specific transfusion via the portal venous route induces prolongation of H‐2‐compatible but not H‐2‐incompatible cardiac graft survival'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS